HPV E6 proteins interact with specific PML isoforms and allow distinctions to be made between different POD structures

Oncogene

Volumn 23, Issue 27, 2004, Pages 4662-4672

  Guccione, Ernesto ^a   Lethbridge, Katherine J ^b   Killick, Neil ^b   Leppard, Keith N ^b   Banks, Lawrence ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

E6; HPV; PML; PODs

Indexed keywords

ISOPROTEIN; ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEASOME; VIRUS PROTEIN; CYSTEINE PROTEINASE; MESSENGER RNA; MONOCLONAL ANTIBODY; MULTIENZYME COMPLEX;

ANIMAL CELL; ARTICLE; CELL AGING; IN VIVO CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; PROTEIN TARGETING; WART VIRUS; ALTERNATIVE RNA SPLICING; ANIMAL; CELL NUCLEUS; CELL TRANSFORMATION; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; CYTOLOGY; FIBROBLAST; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HUMAN; METABOLISM; PAPILLOMA VIRUS; RAT; SERODIAGNOSIS; TUMOR CELL LINE; VIROLOGY; WESTERN BLOTTING;

ANIMALIA; DNA VIRUSES; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; PAPOVAVIRIDAE;

ALTERNATIVE SPLICING; ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; CYSTEINE ENDOPEPTIDASES; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; MICROSCOPY, CONFOCAL; MULTIENZYME COMPLEXES; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PRECIPITIN TESTS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN ISOFORMS; RATS; RNA, MESSENGER;

EID: 2942711737     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207631     Document Type: Article

References (61)

1. Ahn JH, Brignole III EJ and Hayward GS. (1998). Mol. Cell. Biol., 18, 4899-4913.
2. Ahn JH and Hayward GS. (1997). J. Virol., 71, 4599-4613.
3. Alcalay M, Tomassoni L, Colombo E, Stoldt S, Grignani F, Fagioli M, Szekely L, Helin K and Pelicci PG. (1998). Mol. Cell. Biol., 18, 1084-1093.
4. Alcalay M, Zangrilli D, Fagioli M, Pandolfi PP, Mencarelli A, Lo Coco F, Biondi A, Grignani F and Pelicci PG. (1992). Proc. Natl. Acad. Sci. USA, 89, 4840-4844.
5. Alvarez-Salas LM, Cullinan AE, Siwkowski A, Hampel A and DiPaolo JA. (1998). Proc. Natl. Acad. Sci. USA, 95, 1189-1194.
6. Androphy EJ, Hubbert NL, Schiller JT and Lowy DR. (1987). EMBO J., 6, 989-992.
7. Banks L, Spence P, Androphy E, Hubbert N, Matlashewski G, Murray A and Crawford L. (1987). J. Gen. Virol., 68 (Pt 5), 1351-1359.
8. Barbosa MS and Schlegel R. (1989). Oncogene, 4, 1529-1532.
9. Becker KA, Florin L, Sapp C and Sapp M. (2003). Virology, 314, 161-167.
10. Bedell MA, Jones KH, Grossman SR and Laimins LA. (1989). J. Virol., 63, 1247-1255.
11. Bischof O, Kirsh O, Pearson M, Itahana K, Pelicci PG and Dejean A. (2002). EMBO J., 21, 3358-3369.
12. Butz K, Denk C, Ullmann A, Scheffner M and Hoppe-Seyler F. (2000). Proc. Natl. Acad. Sci. USA, 97, 6693-6697.
13. Chen Z and Chen SJ. (1992). Leuk. Lymphoma, 8, 253-260.
14. Day PM, Roden RB, Lowy DR and Schiller JT. (1998). J. Virol., 72, 142-150.
15. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M and Campisi J. (1995). Proc. Natl. Acad. Sci. USA, 92, 9363-9367.
16. DiPaolo JA, Burkhardt A, Doniger J, Pirisi L, Popescu NC and Yasumoto S. (1986). Toxicol. Pathol., 14, 417-423.
17. Duprez E, Saurin AJ, Desterro JM, Lallemand-Breitenbach V, Howe K, Boddy MN, Solomon E, de The H, Hay RT and Freemont PS. (1999). J. Cell Sci., 112 (Part 3), 381-393.
18. Durst M, Dzarlieva-Petrusevska RT, Boukamp P, Fusenig NE and Gissmann L. (1987). Oncogene, 1, 251-256.
19. Dyck JA, Maul GG, Miller Jr WH, Chen JD, Kakizuka A and Evans RM. (1994). Cell, 76, 333-343.
20. Everett RD, Freemont P, Saitoh H, Dasso M, Orr A, Kathoria M and Parkinson J. (1998). J. Virol., 72, 6581-6591.
21. Everett RD and Maul GG. (1994). EMBO J., 13, 5062-5069.
22. Ferbeyre G, de Stanchina E, Querido E, Baptiste N, Prives C and Lowe SW. (2000). Genes Dev., 14, 2015-2027.
23. Florin L, Sapp C, Streeck RE and Sapp M. (2002a). J. Virol., 76, 10009-10014.
24. Florin L, Schafer F, Sotlar K, Streeck RE and Sapp M. (2002b). Virology, 295, 97-107.
25. Fogal V, Gostissa M, Sandy P, Zacchi P, Sternsdorf T, Jensen K, Pandolfi PP, Will H, Schneider C and Del Sal G. (2000). EMBO J., 19, 6185-6195.
26. Goodwin EC, Yang E, Lee CJ, Lee HW, DiMaio D and Hwang ES. (2000). Proc. Natl. Acad. Sci. USA, 97, 10978-10983.
27. Gostissa M, Hengstermann A, Fogal V, Sandy P, Schwarz SE, Scheffner M and Del Sal G. (1999). EMBO J., 18, 6462-6471.
28. Guccione E, Massimi P, Bernat A and Banks L. (2002). Virology, 293, 20-25.
29. Heino P, Zhou J and Lambert PF. (2000). Virology, 276, 304-314.
30. Ishov AM, Vladimirova OV and Maul GG. (2002). J. Virol., 76, 7705-7712.
31. Jang MS, Ryu SW and Kim E. (2002). Biochem. Biophys. Res. Commun., 295, 495-500.
32. Jensen K, Shiels C and Freemont PS. (2001). Oncogene, 20, 7223-7233.
33. Jiang M and Milner J. (2002). Oncogene, 21, 6041-6048.
34. Kamitani T, Kito K, Nguyen HP, Wada H, Fukuda-Kamitani T and Yeh ET. (1998). J. Biol. Chem., 273, 26675-26682.
35. Kanda T, Watanabe S and Yoshiike K. (1988). Virology, 165, 321-325.
36. Lallemand-Breitenbach V, Zhu J, Puvion F, Koken M, Honore N, Doubeikovsky A, Duprez E, Pandolfi PP, Puvion E, Freemont P and de The H. (2001). J. Exp. Med., 193, 1361-1371.
37. LaMorte VJ, Dyck JA, Ochs RL and Evans RM. (1998). Proc. Natl. Acad. Sci. USA, 95, 4991-4996.
38. Li H and Chen JD. (2000). Curr. Opin. Cell Biol., 12, 641-644.
39. Mantovani F and Banks L. (2001). Oncogene, 20, 7874-7887.
40. Muller S and Dejean A. (1999). J. Virol., 73, 5137-5143.
41. Munger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M and Zacny VL. (2001). Oncogene, 20, 7888-7898.
42. Munger K, Phelps WC, Bubb V, Howley PM and Schlegel R. (1989). J. Virol., 63, 4417-4421.
43. Muratani M, Gerlich D, Janicki SM, Gebhard M, Eils R and Spector DL. (2002). Nat. Cell Biol., 4, 106-110.
44. Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S, Pandolfi PP and Pelicci PG. (2000). Nature, 406, 207-210.
45. Pim D, Massimi P and Banks L. (1997). Oncogene, 15, 257-264.
46. Pearson M and Pelicci PG. (2001). Oncogene, 20, 7250-7256.
47. Rodriguez MS, Dargemont C and Hay RT. (2001). J. Biol. Chem., 276, 12654-12659.
48. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A and zur Hausen H. (1985). Nature, 314, 111-114.
49. Sedman SA, Barbosa MS, Vass WC, Hubbert NL, Haas JA, Lowy DR and Schiller JT. (1991). J. Virol., 65, 4860-4866.
50. Sternsdorf T, Jensen K and Will H. (1997). J. Cell Biol., 139, 1621-1634.
51. Swindle CS, Zou N, Van Tine BA, Shaw GM, Engler JA and Chow LT. (1999). J. Virol., 73, 1001-1009.
52. Torii S, Egan DA, Evans RA and Reed JC. (1999). EMBO J., 18, 6037-6049.
53. von Knebel Doeberitz M, Rittmuller C, zur Hausen H and Durst M. (1992). Int. J. Cancer, 51, 831-834.
54. Vousden KH, Doniger J, DiPaolo JA and Lowy DR. (1988). Oncogene Res., 3, 167-175.
55. Wells SI, Francis DA, Karpova AY, Dowhanick JJ, Benson JD and Howley PM. (2000). EMBO J., 19, 5762-5771.
56. Wiesmeijer K, Molenaar C, Bekeer IM, Tanke HJ and Dirks RW. (2002). J. Struct. Biol., 140, 180-188.
57. Wigler M, Sweet R, Sim GK, Wold B, Pellicer A, Lacy E, Maniatis T, Silverstein S and Axel R. (1979). Cell, 16, 777-785.
58. Wu WS, Vallian S, Seto E, Yang WM, Edmondson D, Roth S and Chang KS. (2001). Mol. Cell Biol., 21, 2259-2268.
59. Zhong S, Muller S, Ronchetti S, Freemont PS, Dejean A and Pandolfi PP. (2000). Blood, 95, 2748-2752.
60. zur Hausen H. (1987). Appl. Pathol., 5, 19-24.
61. zur Hausen H. (2000). J. Natl. Cancer Inst., 92, 690-698.